Healthcare provider profile · identity verified

Randall S Orr, MD

Psychiatry · GREENSBURG, PA · NPI 1710901061

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Trazodone Hcl	Trazodone Hcl	238	35
Quetiapine Fumarate	Quetiapine Fumarate	233	22
Alprazolam	Alprazolam	224	29
Gabapentin	Gabapentin	212	29
Clonazepam	Clonazepam	211	33
Buspirone Hcl	Buspirone Hcl	200	31
Aripiprazole	Aripiprazole	181	29
Fluoxetine Hcl	Fluoxetine Hcl	130	16
Lorazepam	Lorazepam	126	27
Duloxetine Hcl	Duloxetine Hcl	122	15
Lamotrigine	Lamotrigine	120	24
Topiramate	Topiramate	105	18
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	102	suppressed
Olanzapine	Olanzapine	101	14
Benztropine Mesylate	Benztropine Mesylate	94	16
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	93	15
Escitalopram Oxalate	Escitalopram Oxalate	93	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	93	suppressed
Oxcarbazepine	Oxcarbazepine	92	15
Risperidone	Risperidone	83	suppressed
Bupropion Xl	Bupropion Hcl	80	15
Chlorpromazine Hcl	Chlorpromazine Hcl	79	suppressed
Bupropion Hcl Sr	Bupropion Hcl	77	13
Venlafaxine Hcl Er	Venlafaxine Hcl	74	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	70	suppressed
Divalproex Sodium Er	Divalproex Sodium	69	suppressed
Mirtazapine	Mirtazapine	64	14
Amitriptyline Hcl	Amitriptyline Hcl	61	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	61	19
Clozapine	Clozapine	59	suppressed
Diazepam	Diazepam	59	11
Paroxetine Hcl	Paroxetine Hcl	59	11
Propranolol Hcl	Propranolol Hcl	58	suppressed
Sertraline Hcl	Sertraline Hcl	58	12
Lithium Carbonate	Lithium Carbonate	52	suppressed
Lurasidone Hcl	Lurasidone Hcl	52	suppressed
Temazepam	Temazepam	50	suppressed
Vilazodone Hcl	Vilazodone Hcl	48	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	47	suppressed
Donepezil Hcl	Donepezil Hcl	39	suppressed
Lithium Carbonate Er	Lithium Carbonate	35	suppressed
Vraylar	Cariprazine Hcl	35	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	35	suppressed
Clonidine Hcl	Clonidine Hcl	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Prazosin Hcl	Prazosin Hcl	33	suppressed
Doxepin Hcl	Doxepin Hcl	32	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	31	suppressed
Trifluoperazine Hcl	Trifluoperazine Hcl	29	suppressed
Trintellix	Vortioxetine Hydrobromide	26	suppressed
Perphenazine	Perphenazine	25	suppressed
Divalproex Sodium	Divalproex Sodium	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Rexulti	Brexpiprazole	22	suppressed
Clomipramine Hcl	Clomipramine Hcl	21	suppressed
Desmopressin Acetate	Desmopressin Acetate	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Methylphenidate Er	Methylphenidate Hcl	18	suppressed
Modafinil	Modafinil	18	suppressed
Austedo	Deutetrabenazine	17	suppressed
Tetrabenazine	Tetrabenazine	17	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	16	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	16	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	14	suppressed
Haloperidol	Haloperidol	14	suppressed
Latuda	Lurasidone Hcl	14	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	14	suppressed
Lacosamide	Lacosamide	13	suppressed
Paliperidone Er	Paliperidone	13	suppressed
Caplyta	Lumateperone Tosylate	12	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Metformin Hcl	Metformin Hcl	12	suppressed
Fanapt	Iloperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error